☰

David C. Binder, Ph.D. - Publications

Affiliations: 
2013 Cancer Biology University of Chicago, Chicago, IL 
Area:
General Biology, Medicine and Surgery, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Oweida AJ, Darragh L, Phan A, Binder D, Bhatia S, Mueller A, Van Court B, Milner D, Raben D, Woessner R, Heasley L, Nemenoff R, Clambey E, Karam SD. The role of regulatory T cells in the response to radiation therapy in head and neck cancer. Journal of the National Cancer Institute. PMID 30863843 DOI: 10.1093/Jnci/Djz036  0.405
2019 Zhai L, Ladomersky E, Lauing KL, Wu M, Scholtens DM, Savoor R, Zhang B, Wu JD, Horbinski C, Lukas RV, Binder DC, Wainwright DA. Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg . (2017). Oncoimmunology. 8: 1548242. PMID 30723577 DOI: 10.1080/2162402X.2018.1548242  0.302
2018 Oweida A, Hararah M, Phan AV, Binder DC, Bhatia S, Lennon S, Bukkapatnam S, Van Court B, Uyanga N, Darragh L, Kim HM, Raben D, Tan AC, Heasley L, Clambey ET, et al. Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30042205 DOI: 10.1158/1078-0432.Ccr-18-1038  0.42
2018 Ladomersky E, Zhai L, Lenzen A, Lauing KL, Qian J, Scholtens DM, Gritsina G, Sun X, Liu Y, Yu F, Gong W, Liu Y, Jiang B, Tang Z, Patel R, ... ... Binder DC, et al. IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29500275 DOI: 10.1158/1078-0432.Ccr-17-3573  0.427
2018 Binder DC, Ladomersky E, Lenzen A, Zhai L, Lauing KL, Otto-Meyer SD, Lukas RV, Wainwright DA. Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma. Translational Cancer Research. 7. DOI: 10.21037/Tcr.2018.03.36  0.308
2018 Oweida AJ, Hararah M, Phan A, Bhatia S, Lennon S, Binder D, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. Abstract 2766: Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation in anti-PD-L1 refractory head and neck cancer Cancer Research. 78: 2766-2766. DOI: 10.1158/1538-7445.Am2018-2766  0.505
2017 Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, Graham C, Binder D, Serkova N, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma. Oncoimmunology. 6: e1356153. PMID 29123967 DOI: 10.1080/2162402X.2017.1356153  0.481
2017 Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Győrffy B, Brastianos PK, Binder D, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA. Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28751450 DOI: 10.1158/1078-0432.Ccr-17-0120  0.449
2017 Binder DC, Wainwright DA. The Boosting Potential of Bacteria in Cancer Immunotherapy. Trends in Molecular Medicine. PMID 28583420 DOI: 10.1016/J.Molmed.2017.05.008  0.392
2017 Zhai L, Ladomersky E, Dostal CR, Lauing K, Swoap K, Billingham LK, Gritsina G, Wu M, McCusker RH, Binder DC, Wainwright DA. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma. Brain, Behavior, and Immunity. PMID 28179106 DOI: 10.1016/J.Bbi.2017.01.022  0.539
2017 Zhai L, Ladomersky E, Lauing K, Wu M, Genet M, Gritsina G, Gyorffy B, Brastianos P, Binder D, Sosman J, Giles F, James CD, Horbinski CM, Stupp R, Wainwright D. IMMU-66. IDO1 EXPRESSION STRATIFIES PATIENT SURVIVAL AND IS REGULATED BY TUMOR INFILTRATING T CELLS IN HUMAN GLIOBLASTOMA Neuro-Oncology. 19: vi127-vi127. DOI: 10.1093/Neuonc/Nox168.523  0.507
2016 Ladomersky E, Genet M, Zhai L, Gritsina G, Lauing KL, Lulla RR, Fangusaro J, Lenzen A, Kumthekar P, Raizer JJ, Binder DC, James CD, Wainwright DA. Improving vaccine efficacy against malignant glioma. Oncoimmunology. 5: e1196311. PMID 27622066 DOI: 10.1080/2162402X.2016.1196311  0.367
2016 Binder DC, Arina A, Wen F, Tu T, Zhao M, Hoffman RM, Wainwright DA, Schreiber H. Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium. Oncoimmunology. 5: e1130207. PMID 27471609 DOI: 10.1080/2162402X.2015.1130207  0.692
2016 Binder DC, Davis AA, Wainwright DA. Immunotherapy for cancer in the central nervous system: Current and future directions. Oncoimmunology. 5: e1082027. PMID 27057463 DOI: 10.1080/2162402X.2015.1082027  0.449
2015 Zhai L, Spranger S, Binder DC, Gritsina G, Lauing KL, Giles FJ, Wainwright DA. Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26519060 DOI: 10.1158/1078-0432.Ccr-15-0420  0.409
2015 Binder DC, Fu YX, Weichselbaum RR. Radiotherapy and immune checkpoint blockade: potential interactions and future directions. Trends in Molecular Medicine. PMID 26091823 DOI: 10.1016/J.Molmed.2015.05.007  0.31
2014 Binder DC, Schreiber H. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter. Cancer Research. 74: 632; discussion 635. PMID 24408925 DOI: 10.1158/0008-5472.Can-13-2216  0.658
2014 Arina A, Schreiber K, Binder DC, Karrison TG, Liu RB, Schreiber H. Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression. Journal of Immunology (Baltimore, Md. : 1950). 192: 1286-93. PMID 24367029 DOI: 10.4049/Jimmunol.1202498  0.687
2014 Binder DC, Wen F, Arina A, Tu T, Zhao M, Hoffman RM, Schreiber H. Effect of adoptive T-cell therapy and intratumoral heat-killed bacteria on large tumors. Journal of Clinical Oncology. 32: 11112-11112. DOI: 10.1200/Jco.2014.32.15_Suppl.11112  0.7
2013 Binder DC, Schreiber H. High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies. Oncoimmunology. 2: e26704. PMID 24563823 DOI: 10.4161/Onci.26704  0.623
2013 Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, Karrison T, Burnette B, Idel C, Zhao M, Hoffman RM, Munn DH, Rowley DA, Schreiber H. Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer. Cancer Immunology Research. 1: 123-33. PMID 24455752 DOI: 10.1158/2326-6066.Cir-13-0058  0.675
2013 Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, Kranz DM, Meredith SC, Rowley DA, Schreiber H. Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell. 23: 516-26. PMID 23597565 DOI: 10.1016/J.Ccr.2013.03.018  0.614
2013 Tretiakova M, Antic T, Binder D, Kocherginsky M, Liao C, Taxy JB, Oto A. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Human Pathology. 44: 495-502. PMID 23069258 DOI: 10.1016/J.Humpath.2012.06.009  0.324
2012 Liu RB, Engels B, Arina A, Schreiber K, Hyjek E, Schietinger A, Binder DC, Butz E, Krausz T, Rowley DA, Jabri B, Schreiber H. Densely granulated murine NK cells eradicate large solid tumors. Cancer Research. 72: 1964-74. PMID 22374983 DOI: 10.1158/0008-5472.Can-11-3208  0.626
Show low-probability matches.